Kynurenine pathway is dependent on Aryl hydrocarbon receptor (AhR) to some extent; its upregulation may lead to cancer progression via down-regulating T-cell phenotype, and then suppressing antitumor immune responses (Li et al., 2011; Adams et al., 2012; Platten et al., 2019). The gene discussed is AHR; the disease is cancer.